Saliva test for Ebola detection under development
from Dental Tribune International
In collaboration with two U.S. scientific institutions, Ceres Nanosciences, a biotechnology company specializing in diagnostic products, is planning to develop a new method to detect the presence of the Ebola virus in saliva. Since current methods for diagnosing Ebola rely on blood samples, the four-month project aims to find a more effective and noninvasive alternative.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063